5
Participants
Start Date
January 31, 2005
Primary Completion Date
July 31, 2009
Study Completion Date
May 31, 2012
AdHer-2/neu transduced dendritic cells
Group 1 1 ×10'7 expanded cells (2.5 ×106 DCs per injection site) Group 2 5 ×10'7 expanded cells (1.25 ×107 DCs per injection site) Group 3 1 ×10'8 expanded cells (2.5 ×107 DCs per injection site)
Ontario Cancer Research Network
NETWORK
Canadian Breast Cancer Research Alliance
OTHER
Ontario Clinical Oncology Group (OCOG)
OTHER